Semaglutide, originally developed for addressing type 2 glucose , has become a compelling option for weight reduction . This therapy works by influencing a bodily signal that regulates food intake and delays gastric transit , leading to a decrease in energy consumption . Initial data have revealed substantial slimming effects in people who are over